Recombinant Human IFNL2 Protein, His-tagged
Recombinant human IFNL2 (NP_742150.1) (Val26-Val200) was expressed with a polyhistidine tag at the C-terminus.
Predicted N Terminal:
Lyophilized from sterile PBS, pH 7.4, 5%~8% trehalose and mannitol.
Measured in antiviral assays using HepG2 cells infected with vesicμLar stomatitis virus. The ED50 for this effect is typically 1.7-6.8 ng/mL.
The recombinant human IFNL2 consists 185 amino acids and predicts a molecular mass of 21.1 kDa.
< 1.0 EU per μg of the protein as determined by the LAL method.
>90 % as determined by SDS-PAGE.
Samples are stable for up to twelve months from date of receipt at -70ºC.
Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 ug/ul. Centrifuge the vial at 4ºC before opening to recover the entire contents.